Invention Grant
US08168437B2 Quantitative determination of risedronate in urine by SPE-LC-MS-MS
有权
通过SPE-LC-MS-MS定量测定尿中利塞膦酸盐
- Patent Title: Quantitative determination of risedronate in urine by SPE-LC-MS-MS
- Patent Title (中): 通过SPE-LC-MS-MS定量测定尿中利塞膦酸盐
-
Application No.: US12554111Application Date: 2009-09-04
-
Publication No.: US08168437B2Publication Date: 2012-05-01
- Inventor: Liduo Shen , Yongyi Luo
- Applicant: Liduo Shen , Yongyi Luo
- Applicant Address: US NJ Bridgewater
- Assignee: Sanofi-Aventis U.S. LLC
- Current Assignee: Sanofi-Aventis U.S. LLC
- Current Assignee Address: US NJ Bridgewater
- Agency: Scully, Scott, Murphy & Presser, P.C.
- Agent Serena Farquharson-Torres
- Main IPC: G01N30/84
- IPC: G01N30/84

Abstract:
The disclosure provides a method for quantitatively determining risedronate in a urine sample by adding an internal standard to the urine sample, applying the urine sample to a polymeric water-wettable reverse-phased sorbent preconditioned with methanol, washing the sorbent with TEA in water and formic acid in methanol, eluting risedronate with a mixture of methanol and water containing EDTA under vacuum, evaporating the eluted solution and reconstituting with a mixture of methanol and NH4OH buffer and analyzing the sample with a LC-MS/MS system.
Public/Granted literature
- US20090320572A1 THE QUANTITATIVE DETERMINATION OF RISEDRONATE IN URINE BY SPE-LC-MS-MS Public/Granted day:2009-12-31
Information query